Life Sciences and Industrial Biochemistry

Filter by Category Archive
Clear all
Subscribe to our news
  • Understanding the EU Pharma Package and how to prepare for its implementation in 2028

    Mar 19, 2026 | Tags: Patents , Healthcare , Life Sciences and Industrial Biochemistry , Pharmaceutical chemistry and biopharmaceuticals , Pharmaceutical and Biosciences

  • Understanding the EU Pharma Incentives Review

    Feb 26, 2026 | Tags: Patents , Healthcare , Life Sciences and Industrial Biochemistry , Pharmaceutical chemistry and biopharmaceuticals , Pharmaceutical and Biosciences

  • UK Supreme Court endorses EPO’s approach to computer-implemented inventions and discards Aerotel

    Feb 12, 2026 | Tags: Patents , IP Insight , Aerospace , Automotive , Battery technology , Defence and Security , Engineering , Energy and environment , Healthcare , Life Sciences and Industrial Biochemistry , Pharmaceutical chemistry and biopharmaceuticals , Pharmaceutical and Biosciences , Renewable energy , Sports , Software , Transportation

  • Medicine Authorisations and SPCs in the UK after the implementation of the Windsor Framework

    Nov 11, 2024 | Tags: Patents , IP Insight , Life Sciences and Industrial Biochemistry , Pharmaceutical chemistry and biopharmaceuticals , Pharmaceutical and Biosciences

  • News Flash - Update to EPO’s practices concerning the filing of sequence listings for European divisional applications

    Oct 5, 2023 | Tags: Patents , IP Insight , Life Sciences and Industrial Biochemistry , Pharmaceutical chemistry and biopharmaceuticals , Pharmaceutical and Biosciences

  • Compliant sequence listings for European divisionals post July 2022

    Mar 10, 2023 | Tags: Patents , Life Sciences and Industrial Biochemistry , Pharmaceutical chemistry and biopharmaceuticals , Pharmaceutical and Biosciences

  • Covid vaccine patent waivers – the opinion of our vaccine IP specialist

    May 6, 2021 | Tags: Patents , IP Insight , Healthcare , Life Sciences and Industrial Biochemistry , Pharmaceutical chemistry and biopharmaceuticals , Pharmaceutical and Biosciences

  • Medical inventions – a European perspective

    Jan 19, 2021 | Tags: Patents , IP Insight , Healthcare , Life Sciences and Industrial Biochemistry , Pharmaceutical chemistry and biopharmaceuticals

  • No SPCs for new therapeutic applications of old drugs – CJEU overturns Neurim

    Jul 16, 2020 | Tags: Patents , IP Insight , Healthcare , Life Sciences and Industrial Biochemistry , Pharmaceutical chemistry and biopharmaceuticals